BioNTech said that it is acquiring the Chinese drugmaker Biotheus for $800 million to bolster its cancer strategy. The two ...

J&J’s filing is based on results from the phase 3 AQUILA trial. Among 390 patients with high-risk smoldering multiple myeloma ...

CuraTeQ Biologics' EMA GMP certification marks a key milestone in Aurobindo Pharma's expansion into biosimilars, with three ...

The US Food and Drug Administration announced a proposal to remove oral phenylephrine – a common ingredient in many popular ...

The Consumer Healthcare Products Association, which represents manufacturers and marketers of over-the-counter medicines, ...

The FDA says oral phenylephrine, used in many over-the-counter cough and cold medicines, "is not effective as a nasal ...

An extensive review determined that the ingredient, oral phenylephrine, doesn’t actually relieve nasal congestion.

Through harnessing innovations in its regulatory processes, including digital transformation in health care, BPOM is ...

The Canadian healthcare-focused royalty company said Monday that the royalty interest in the worldwide net sales of all formulations of sebetralstat from KalVista Pharmaceuticals was acquired for an ...

The Central Bureau of Investigation (CBI) is investigating unauthorised purchases of medicines and medical equipment at RG ...

In this article, we take a look at five biotech companies developing potentially transformative medicines to treat cystic ...